Obesity management Market is experiencing moderate growth. Market Research Future (MRFR) has published a research report about the global obesity management market that envisions remarkable increase for this market with 8.4% CAGR (Compound Annual Growth Rate) during the forecast period between 2015 and 2022. In terms of cash, the market is expected to be worth the US $ 6.2 bn.
Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/2690
The key factors driving the market include easily accessible takeaway meals, growing awareness of weight management techniques, growing initiatives by the market players in collaboration, growing initiatives by government to raise awareness about the adverse impact of obesity on health, growth in nuclear families, growing patient population, increasing demand for inexpensive fast food, research and development (R & D) activities, and rising working population. However, the availability of low-cost alternatives, the high cost of customization, and post-surgical side effects are the major restraining factors affecting the market growth.
The global obesity management market has been segmented on the basis of lifestyle changes, prescription weight-loss medication, surgery, and lastly region. Based on lifestyle changes, this market has been segmented into dietary changes, exercise, and others. Prescription weight-loss medication based segmentation segments the market into buproprion & naltrexone (Contrave), lorcaserin (Belviq), orlistat (Xenical), phentermine & topiramate (Qsymia), liraglutide (Saxenda), and others. On the basis of surgery, the market has been segmented into biliopancreatic diversion with duodenal switch, gastric bypass surgery, laparoscopic adjustable gastric banding (LAGB), and others.
Global Obesity Management Market: Segmental Analysis
The global obesity management market has been segmented on the basis of prescription, surgery, and lifestyle changes.
By mode of prescription, the obesity management market has been segmented into orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), bupropion and naltrexone (Contrave), liraglutide (Saxenda), and others.
By mode of surgery, the obesity management market has been segmented into gastric bypass surgery, laparoscopic adjustable gastric banding (LAGB), biliopancreatic diversion with duodenal switch, and others. Among these, the gastric bypass surgery segment is estimated to be the fastest growing market owing to faster recovery time, improved psychological status, and improved longevity.
By mode of lifestyle changes, the global obesity management market has been segmented into dietary changes, exercise, and others.
Geographically, the Obesity Management Market spans across regions namely, Europe, North America, Asia Pacific, and Rest-of-the-World (RoW).
Among all the regions, Asia Pacific is considered to expand at a rapid pace and is estimated to retain its dominance. The growth is credited to the lack of physical activity, unhealthy life balance, and poor diet. Moreover, the government is highly focusing on the latest technologies and advanced treatment, which is further initiating R&D activities for the development of new drugs. In this region, China and India are extensively focusing on the market players owing to the increasing purchasing power coupled with a huge patient pool as compared to other economies.
The North American region is likely to project as the largest market for obesity management owing to the presence of an obese population along with advanced treatment options. For instance, as per the CDC, approximately 37.9% of the adults were suffering from obesity from 2013 to 2014. Around 70.7% of the adult population were suffering from overweight.
February 13, 2019: GI Dynamics Inc., a medical device company developing EndoBarrier for patients suffering from obesity and type 2 diabetes, has recently announced that they have received the Institutional Review Board (IRB) approval in order to conduct its pivotal trial of EndoBarrier.
The prominent players operating the global obesity management market are Merck Sharp & Dohme Corp. a subsidiary of Merck & Co. Inc. (US), Pfizer Inc. (US), Ethicon Inc. (U.S.), AstraZeneca (UK), Apollo Endosurgery (U.S.), Herbalife Ltd. (U.S.), and F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline Plc. (UK).
- Hospitals and Clinics
- Anti-obesity Drugs manufacturers and suppliers
- Weight loss equipment manufacturers and suppliers
- Government and Independent Regulatory Authorities
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Potential Investors
LIST OF TABLES
Table 1 Global Obesity Management Market By Prescription Weight-Loss Medication
Table 2 Global Obesity Management Market By Surgery
Table 3 Global Obesity Management Market By End User
Table 4 Global Obesity Management Market By Region
List Of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Global Obesity Management Market, By Prescription Weight-Loss Medication
Figure 4 Global Obesity Management Market, By Surgery
Figure 5 Global Obesity Management Market, By End User
Read Full Report With TOC @https://www.marketresearchfuture.com/reports/obesity-management-market-2690
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312